High Flow Nasal Cannula for Management of Tuberculous ARDS in Immunocompromised – A Vision or an Illusion

Authors

  • Robin Choudhary Department of Pulmonary, Critical care and sleep medicine, AICTS, India
  • Vikas Marwah Department of Pulmonary, Critical care and sleep medicine, AICTS, India
  • Manish Singh Department of Pulmonary, Critical care and sleep medicine, AICTS, India
  • Simple Gupta Department of Ophthalmology, CHSC, Pune, India

DOI:

https://doi.org/10.3126/saarctb.v19i1.39953

Keywords:

HFNS oxygen therapy, ARDS, Tuberculosis, Immunocompromised

Abstract

Tuberculosis (TB), although commonly thought to be a chronic pulmonary disease, indeed has protean manifestations. One of its varied acute presentations is Tuberculous ARDS, which is a rare but fatal form of TB with mortality reported as high as 69-80%. Here we report a case of sputum smear-positive MDR miliary tuberculosis with tuberculous ARDS in a patient with AIDS managed with HFNC oxygen therapy. Diagnosis of tuberculosis was based on clinical radiological, microbiological and molecular evidence. The diagnosis of ARDS was established as per Berlin definition. The patient was successfully managed with HFNC oxygen therapy along with second line anti tubercular treatment (ATT) and supportive measures.

Downloads

Download data is not yet available.
Abstract
96
PDF
72

Author Biographies

Robin Choudhary, Department of Pulmonary, Critical care and sleep medicine, AICTS, India

Resident

Vikas Marwah, Department of Pulmonary, Critical care and sleep medicine, AICTS, India

Senior Advisor

Downloads

Published

2021-07-30

How to Cite

Choudhary, R., Marwah, V., Singh, M., & Gupta, S. (2021). High Flow Nasal Cannula for Management of Tuberculous ARDS in Immunocompromised – A Vision or an Illusion. SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, 19(1), 29–32. https://doi.org/10.3126/saarctb.v19i1.39953

Issue

Section

Case Studies